Rayvow

lasmiditan succinate · Eli Lilly Nederland B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rayvow, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: EMA Authorised: Rayvow (lasmiditan succinate) — Eli Lilly Nederland B.V.